Haleon Sells Nicotine Replacement Therapy Business to Dr. Reddy’s for $630 Million

1. Deal Value: Haleon has agreed to sell its nicotine replacement therapy business to Dr. Reddy's for $630 million.
2. Business Scope: The sale includes Haleon's ex-US nicotine replacement therapy business.
3. Date of Announcement: The deal was announced on June 26, 2024.
4. Parties Involved: Haleon is the seller, and Dr. Reddy's is the buyer in this transaction.
5. Industry Impact: This sale is significant in the pharmaceutical industry, particularly in the nicotine replacement therapy market.